Anzeige
Mehr »
Login
Mittwoch, 15.01.2025 Börsentäglich über 12.000 News von 681 internationalen Medien
Löst diese riesige Entdeckung die Kupferkrise der KI? So ändert sich die Rechnung durch diesen Explorer!!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2DKAC | ISIN: FR0013227113 | Ticker-Symbol: SOH1
Tradegate
15.01.25
15:41 Uhr
84,45 Euro
+1,65
+1,99 %
1-Jahres-Chart
SOITEC SA Chart 1 Jahr
5-Tage-Chart
SOITEC SA 5-Tage-Chart
RealtimeGeldBriefZeit
84,6084,7016:31
84,6584,7016:31
GlobeNewswire (Europe)
579 Leser
Artikel bewerten:
(2)

SOITEC: Soitec continues its collaboration with MIT's Microsystems Technology Laboratories, thereby strengthening its presence in the United States

Finanznachrichten News

Soitec continues its collaboration with MIT's Microsystems Technology Laboratories, thereby strengthening its presence in the United States

  • Soitec continues its research and membership agreement with MIT's Microsystems Technology Laboratories. This agreement covers research in innovative semiconductor materials for diverse applications, including mobile communications, power devices, sensors and quantum computing.

  • This cooperation embodies one of the founding principles of Soitec's innovation strategy, which combines technological expertise, collaboration with centres of excellence, and integration within regional ecosystems.

Bernin (France), December 12th, 2024 - Soitec (Euronext - Tech Leaders), a world leader in the design and manufacture of innovative semiconductor materials, today announced the continuation of its research collaboration with the Microsystems Technology Laboratories (MTL) of the Massachusetts Institute of Technology (MIT), further solidifying its presence in the North American semiconductor sector.

This initiative aims to diversify technological collaborations and anticipate the future needs of the industry.

In the United States, Soitec is intensifying its efforts amidst favourable industrial and regulatory dynamics supporting semiconductor development. In this respect, MIT plays a key role through its Microsystems Technology Laboratories (MTL), in which Soitec is now a member of the Industrial Advisory Board, which actively contributes to defining strategic research directions in microelectronics.

Christophe Maleville, Soitec's Senior Executive Vice President in charge of Innovation and Chief Technology Officer, commented on the partnership: "The agreement between Soitec and MIT reflects a global strategy centred on excellence and impact. By joining forces with a world-renowned institution like MIT, Soitec gains unique access to cutting-edge technological advances and an exceptional innovation ecosystem. Combining innovation, technological expertise and regional ecosystem engagement, Soitec is reinforcing its position to do important research in the field"

Tomás Palacios, Director of MTL and Professor at MIT, added: "We are proud to have Soitec as a member of the MIT Microsystems Technology Laboratories. Soitec is a technology leader in the development and commercialization of advanced semiconductor substrates, and we are excited to be able to work closely with their team in the development of the next generation of semiconductor materials and devices."

International Collaboration: The Cornerstone of Soitec's Innovation Strategy

Soitec collaborates with industrial innovation platforms, academic institutions and research centres, reflecting a long-term vision and a commitment to partnering with centres of excellence.

In Europe, Soitec has established strategic partnerships with institutions like Imec, Leti and Fraunhofer, enhancing its regional expertise and its deep understanding of client needs.

In Asia, Soitec has collaborated with organizations such as the Institute of Microelectronics of Singapore (IME) and the National University of Singapore (NUS) for years, with plans to expand its innovation activities to Japan, a key player in materials development.

Soitec is pursuing high-impact innovation projects in the United States, forming partnerships with key centres identified under the CHIPS Act and engaging with universities like UC San Diego and UC Riverside.

These initiatives span domains such as mobility, artificial intelligence and advanced packaging, underscoring Soitec's ambition to remain at the forefront of technological advancements.

About Soitec

Soitec (Euronext - Tech Leaders), a world leader in innovative semiconductor materials, has been developing cutting-edge products delivering both technological performance and energy efficiency for over 30 years. From its global headquarters in France, Soitec is expanding internationally with its unique solutions, and generated sales of 1 billion Euros in fiscal year 2023-2024. Soitec occupies a key position in the semiconductor value chain, serving three main strategic markets: Mobile Communications, Automotive and Industrial, and Edge and Cloud AI. The company relies on the talent and diversity of its 2,300 employees, representing 50 different nationalities, working at its sites in Europe, the United States and Asia. Soitec has registered over 4,000 patents.
Soitec, SmartSiC and Smart Cut are registered trademarks of Soitec.

For more information visit our Websiteand follow us on LinkedInand X
Media Relations: media@soitec.com
Investor Relations:
investors@soitec.com

Attachment

  • 2024-12-12 PR MIT_Soitec_ version VE (https://ml-eu.globenewswire.com/Resource/Download/31582de3-da91-4afb-8ccf-d3bab7f23aea)

© 2024 GlobeNewswire (Europe)
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.